Article citationsMore >>

Busch R., Mellins E.D., “Developing and shedding inhibitions: how MHC class II molecules reach maturity, “Curr Opin Immunol, 8 (1).51-58. Feb. 1996.

has been cited by the following article:

Article

Donor Selection in Allogeneic Stem Cell Transplantation

1Department of Hematology, Faculty of Medicine, Inonu University, Malatya, Turkey


American Journal of Clinical Medicine Research. 2014, Vol. 2 No. 1, 32-35
DOI: 10.12691/ajcmr-2-1-8
Copyright © 2014 Science and Education Publishing

Cite this paper:
Mehmet Ali ERKURT, Ilhami BERBER, Irfan KUKU, Emin KAYA, Ilknur NIZAM. Donor Selection in Allogeneic Stem Cell Transplantation. American Journal of Clinical Medicine Research. 2014; 2(1):32-35. doi: 10.12691/ajcmr-2-1-8.

Correspondence to: Ilhami  BERBER, Department of Hematology, Faculty of Medicine, Inonu University, Malatya, Turkey. Email: drilhamiberber@hotmail.com

Abstract

Allogeneic hematopoietic stem cell transplant is safe and curative treatment modality for many hematologic diseases. Expanding alternative donor options such as haploidentical hematopoietic stem cell transplantation and umbilical cord blood, taken together with enhanced outcomes of matched unrelated donors, has resulted in a advisable donor for most patients with an hematopoietic stem cell transplantation indication. This review article provides improved patient selection, offers hope for decreasing relapse and improving outcomes for in patients applied allogeneic hematopoietic stem cell transplant.

Keywords